Latest Breaking News On - Abbott vascular inc - Page 1 : comparemela.com

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2023,.

New yorkUnited statesEden prairieGary maharajSurmodics incAbbott vascular incQuarter fiscalRecent businessEndovascular issuesLow profileThrombectomy systemMedical deviceVitro diagnosticsAbbott vascularCall todayPrivate securities litigation reform act

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Fina

EDEN PRAIRIE, Minn. (BUSINESS WIRE) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2023, and updated its financial guidance for fiscal year ending Septemb.

New yorkUnited statesEden prairieGary maharajAbbott vascular incSurmodics incQuarter fiscalRecent businessEndovascular issuesLow profileThrombectomy systemMedical deviceVitro diagnosticsAbbott vascularCall todayPrivate securities litigation reform act

Surmodics : Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

Surmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance August 2, 2023 07:00 a.m. ET .

Eden prairieUnited statesGary maharajJack powellSurmodics incAbbott vascular incDrug administrationSurmodics reports third quarterFiscal yearQuarter fiscalDistribution agreementRecent business highlightsThrombectomy system retrospective registryLow profileThrombectomy systemAbbott vascular

Surmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Fina

EDEN PRAIRIE, Minn. (BUSINESS WIRE) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its third quarter ended June 30, 2023, and updated its financial guidance for its fiscal year ending Septemb.

Eden prairieUnited statesGary maharajDrug administrationSurmodics incAbbott vascular incQuarter fiscalDistribution agreementRecent businessThrombectomy system retrospective registryLow profileThrombectomy systemAbbott vascularPounce venous thrombectomy systemMedical deviceMonths ended june

Claims in Calif Abbott Coronary Catheter Case Dismissed with Leave to Amend

Claims in Calif Abbott Coronary Catheter Case Dismissed with Leave to Amend
harrismartin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from harrismartin.com Daily Mail and Mail on Sunday newspapers.

United statesAlexg tseAbbott vascular incUs district courtAbbott vascularJudge alexNorthern district